Skip to main content
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. — Investor Relations & Filings

Ticker · SBFM ISIN · US8677817004 LEI · 5299005Y64EHRQDQ2Q25 US Manufacturing
Filings indexed 382 across all filing types
Latest filing 2026-05-29 Share Issue/Capital Cha…
Country US United States of America
Listing US SBFM

About Sunshine Biopharma Inc.

https://www.sunshinebiopharma.com/

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Share Issue/Capital Change Classification · 85% confidence The document is a Form 8-K filing under Item 5.07 "Submission of Matters to a Vote of Security Holders," wherein the company discloses shareholder consent approving new issuance of shares in excess of 20% of outstanding shares at a discount and warrant exercise price/number adjustments. This constitutes an announcement of a new share issuance and related changes to the capital structure. Therefore, it best fits the "Share Issue/Capital Change" category.
2026-05-29 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K reporting the entry into a placement agent agreement and closing of a public offering of equity units and warrants, describing terms and proceeds. This is a direct update on the company’s fundraising and capital structure. Such disclosures fall under Capital/Financing Update.
2026-05-19 English
PROSPECTUS
Share Issue/Capital Change Classification · 89% confidence The document is a prospectus filed under Rule 424(b)(4) for an S-1 registration of new Common Units, Pre-Funded Units, and Series C Warrants, detailing the terms of the offering, use of proceeds, and share counts. It is a securities issuance/registration document announcing a capital raise and change in share capital. Per FinancialReports definitions, this falls under Share Issue/Capital Change (SHA), not a simple announcement or regulatory certification.
2026-05-19 English
10-Q - Sunshine Biopharma Inc. (0001402328) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
8-K - Sunshine Biopharma Inc. (0001402328) (Filer)
Regulatory Filings
2026-04-09 English
10-K - Sunshine Biopharma Inc. (0001402328) (Filer)
Annual Report FY 2025
2026-04-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.